[Entactogen and designer drugs (2)].
Naito
Hiroshi
H
D000818:Animals; D000697:Central Nervous System Stimulants / Q000009:adverse effects / Q000493:pharmacokinetics / Q000506:poisoning; D015198:Designer Drugs; D004347:Drug Interactions; D006801:Humans; D001523:Mental Disorders / Q000139:chemically induced; D018817:N-Methyl-3,4-methylenedioxyamphetamine / Q000009:adverse effects / Q000493:pharmacokinetics / Q000506:poisoning; D012701:Serotonin / Q000172:deficiency; D013375:Substance Withdrawal Syndrome
D000697:Central Nervous System Stimulants; D015198:Designer Drugs; D012701:Serotonin; D018817:N-Methyl-3,4-methylenedioxyamphetamine